BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8137469)

  • 1. Combination therapy of transcatheter chemoembolization and percutaneous ethanol injection therapy for unresectable hepatocellular carcinoma.
    Kato T; Saito Y; Niwa M; Ishiguro J; Ogoshi K
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S115-8. PubMed ID: 8137469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study.
    Koda M; Murawaki Y; Mitsuda A; Oyama K; Okamoto K; Idobe Y; Suou T; Kawasaki H
    Cancer; 2001 Sep; 92(6):1516-24. PubMed ID: 11745230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma].
    Chen XM; Luo PF; Lin HH; Zhou ZJ; Shao PJ; Fu L; Li WK
    Ai Zheng; 2004 Jul; 23(7):829-32. PubMed ID: 15248922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of choice for unresectable small liver cancer: percutaneous ethanol injection therapy or transarterial chemoembolization therapy.
    Horiguchi Y; Sekoguchi B; Imai H; Suzuki T; Kubo H; Itoh H; Itoh M
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S111-4. PubMed ID: 8137468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
    Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of transcatheter arterial embolization and percutaneous ethanol injection for hepatocellular carcinoma: comparison of efficacies of doxorubicin and epirubicin in transcatheter arterial embolization.
    Nakamura S; Tanaka K
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-46-S6-49. PubMed ID: 9151916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transarterial chemoembolization combination therapy vs monotherapy in unresectable hepatocellular carcinoma: a meta-analysis.
    Li L; Tian J; Liu P; Wang X; Zhu Z
    Tumori; 2016 Jun; 2016(3):301-10. PubMed ID: 27002950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of combined therapy with chemoembolization and ethanol injection for advanced hepatocellular carcinoma.
    Yamamoto K; Masuzawa M; Kato M; Kurosawa K; Kaneko A; Ishida H; Imamura E; Park NJ; Shirai Y; Fujimoto K; Michida T; Hayashi N; Ikeda M
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-50-S6-55. PubMed ID: 9151917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
    Dohmen K; Shirahama M; Shigematsu H; Miyamoto Y; Torii Y; Irie K; Ishibashi H
    Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualized treatment models based on blood supply characteristics in hepatocellular carcinoma using color Doppler hemodynamics.
    Si Q; Mu H; Yan G; Qian X; Xu C; Wang X; Tong W
    Hepatogastroenterology; 2007 Mar; 54(74):334-41. PubMed ID: 17523269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization.
    Bartolozzi C; Lencioni R; Caramella D; Vignali C; Cioni R; Mazzeo S; Carrai M; Maltinti G; Capria A; Conte PF
    Radiology; 1995 Dec; 197(3):812-8. PubMed ID: 7480761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma.
    Dettmer A; Kirchhoff TD; Gebel M; Zender L; Malek NP; Panning B; Chavan A; Rosenthal H; Kubicka S; Krusche S; Merkesdal S; Galanski M; Manns MP; Bleck JS
    World J Gastroenterol; 2006 Jun; 12(23):3707-15. PubMed ID: 16773687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term survival of Taiwanese patients with hepatocellular carcinoma after combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection.
    Li YH; Wang CS; Liao LY; Wang CK; Shih LS; Chen RC; Chen PH
    J Formos Med Assoc; 2003 Mar; 102(3):141-6. PubMed ID: 12783129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of transcatheter arterial chemoembolization using cisplatin-lipiodol suspension and percutaneous ethanol injection for treatment of advanced small hepatocellular carcinoma.
    Kamada K; Kitamoto M; Aikata H; Kawakami Y; Kono H; Imamura M; Nakanishi T; Chayama K
    Am J Surg; 2002 Sep; 184(3):284-90. PubMed ID: 12354601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transarterial chemoembolization and percutaneous ethanol injection therapy in patients with hepatocellular carcinoma.
    Kirchhoff T; Chavan A; Galanski M
    Eur J Gastroenterol Hepatol; 1998 Nov; 10(11):907-9. PubMed ID: 9872610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection--a single-center analysis including 132 patients.
    Allgaier HP; Deibert P; Olschewski M; Spamer C; Blum U; Gerok W; Blum HE
    Int J Cancer; 1998 Dec; 79(6):601-5. PubMed ID: 9842968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appraisal of combination treatment for hepatocellular carcinoma: long-term follow-up and lipiodol-percutaneous ethanol injection therapy.
    Tateishi H; Oi H; Masuda N; Yano H; Matsui S; Kinuta M; Maruyama H; Yayoi E; Okamura J
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-81-S6-90. PubMed ID: 9151921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts.
    Tesdal IK; Wikström M; Flechtenmacher C; Filser T; Dueber C
    Cardiovasc Intervent Radiol; 2006; 29(5):778-84. PubMed ID: 16779690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter arterial embolization followed by percutaneous ethanol injection in the treatment of hepatocellular carcinoma.
    Lencioni R; Vignali C; Caramella D; Cioni R; Mazzeo S; Bartolozzi C
    Cardiovasc Intervent Radiol; 1994; 17(2):70-5. PubMed ID: 8013026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on combination therapy with TAE and percutaneous ethanol injection therapy for unresectable hepatocellular carcinoma].
    Tateishi H; Hasuike Y; Kinuta M; Furukawa J; Takata N; Maruyama H; Oi H; Yayoi E; Okamura J
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1492-4. PubMed ID: 8396903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.